BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe Spring® 2014 Press Releases

March 20, 2014BIO-Europe Spring® 2014 partnering event brought over 2,000 life science executives to Turin, Italy last week The eighth annual BIO-Europe Spring® international partnering conference took place last week, March 10–12 in Turin, Italy. The event, held at the Oval Lingotto conference center, welcomed more than 2,000 participants representing over 1,200 companies from 42 countries vying for 2,115 licensing opportunities. More than 10,700 one-to-one meetings took place at the event b...  more ►

March 3, 2014BIO-Europe Spring® 2014 kicks off next week in Turin, ItalyEvent is gathering of life science industry leaders
The eighth annual BIO-Europe Spring® conference kicks off in one week on March 10–12 in Turin, Italy. The event is expected to draw over 2,000 high-level executives from pharma, biotech, venture capital firms, and service companies who will be coming to Turin to engage in one-to-one partnering meetings with innovative biotech startups. Delegates are expected to engage in...  more ►

February 25, 2014"Competition fierce" as big pharma moves to early stage deals The focus for Roche meetings at BIO-Europe Spring® breaks out roughly with a third devoted to ongoing relationships, another third focused on active negotiation and one third opportunistic. "We have to spend more time filtering through that last third, but I can tell you we have found programs over the past year that quickly moved to a high priority status."
more ►

February 12, 2014BIO-Europe Spring® program in Turin will engage executives in provocative topics facing drug development industry Life science executives are quickly filling up the program at the eighth annual BIO-Europe Spring® conference to be held March 10–12, 2014 in Turin, Italy. The international bio-pharma partnering event annually attracts top international executives from established and emerging biotech companies; pharmaceutical companies; private investors including venture capital and priva...  more ►

join the conversation ►

January 29, 2014Spotlight on Turin Business Facts A BUSINESS HUB: According to 2012 data provided by the Register of Enterprises, held by the Torino Chamber of Commerce, the number of businesses based in the Torino Province equals 237,000. LIFE SCIENCES: The Turin Life Science sector comprises medium and large companies operating in the following fields: Medical, Electromedical, and Diagnostic instrumentation; Orthopedic pros...  more ►

join the conversation ►

December 12, 2013Turin, Italy welcomes the 2014 edition of BIO-Europe Spring®Pharmaceutical dealmakers converge upon Italian innovation hub
The eighth annual BIO-Europe Spring® conference will be held March 10–12, 2014 in Turin, Italy at the OVAL Lingotto conference center. The event is recognized by life science insiders as the place for established biotech and early-stage companies to meet and form partnerships with venture capitalists and business development executives from big pharma companies. Investor...  more ►

join the conversation ►



partnering360:Insight Latest headlines from partnering360:Insight

24 March 2014 China partnering grows The Year of the Horse recently began in China, symbolizing dramatic actions, a desire for success and a desire for freedom. Those desires are evidenced in the nation’s choice of reformers as leaders, and in its continued commitment to build an invigorating life sciences community. Last year, 2013, was the prelude. As Greg Scott, President, ChinaBio®, pointed out,“We saw a doubling of partnering deals in 2013, measured by value. The USD 560 million raised through 100 deals in 2012 climbed to USD 1.2 billion and 135 deals in 2013.” That may be just the tip of the proverbial iceberg, as values aren’t announced for every deal. more ►

24 March 2014 BioBay fosters innovation for itself and others Synergy is a theme within BioBay life sciences park. BioBay includes multiple life science disciplines and is designed to promote the natural cross-fertilization of ideas through conversations over coffee as well as through structured meetings and conferences and other interactions. more ►

24 March 2014 Qiming Ventures focuses on China Qiming Ventures is one of the largest and most active healthcare investors in China. Focusing exclusively on China since its founding in 2006, Qiming has invested in more than 90 companies, including 30 life sciences companies developing pharmaceuticals, tools or medical devices. more ►

16 March 2014 Getting to “yes” with effective due diligence There is a soft side of partnering where opportunities are discovered through networking, handshakes and trading information. Eventually there comes the hard part, due diligence where potential partners assess and validate claims and representations. At BIO-Europe Spring® in Turin, a panel of business development executives hardened by negotiations shared their experiences for ensuring a successful due diligence process. more ►

13 March 2014 Big biotechs seek growth in innovative deals with small biotechs "When I look at large pharma, I see zero creativity in the way they go about a deal," said John McDonald of Biogen on the opening plenary panel at BIO-Europe Spring® 2014 in Turin, Italy. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe Spring EBD Group BIO BIO-Europe Spring